Skip to main content
. 2021 Aug 7;10(16):e019950. doi: 10.1161/JAHA.120.019950

Table 1.

Patient Characteristics

Control

n=10

HFpEF

n=20

P Value
Patient characteristics
Women, % 70 75 0.780
Age, y 55±10 65±11 0.023
Height, cm 170.9±9.6 167.9±10.6 0.454
Weight, kg 88.4±19.2 100.8±21.3 0.130
BMI, kg/m2 30.0±4.7 36.0±8.4 0.045
BSA, m2 2.0±0.3 2.2±0.3 0.258
NT‐proBNP, pg/mL 69.9 (25–170) 601.4 (25–3299) 0.015
Hemoglobin, g/dL 13.8±1.5 11.9±1.7 0.012
Creatinine, mg/dL 1.0±0.2 1.2±0.5 0.218
eGFR, mL/min per m2 75.4±9.4 59.3±18.8 0.038
Smoking history, % 30 37 0.724
Medications
ACEI, % 30 45 0.447
β‐Blocker, % 32 35 0.155
Diuretics, % 30 70 0.038
Calcium channel blocker, % 60 30 0.122
Pulmonary function
FVC, % predicted 101±9 80±18 <0.01
FEV1, % predicted 100±14 76±20 <0.01
FEV1/FVC, % predicted 98±8 95±12 0.520
FEF25–75, % predicted 104±40 78±50 0.214
Echocardiography
Ejection fraction, % 63±4 62±3 0.811
LV mass index, g/m2 84.8±22.9 86.1±15.5 0.882
LA volume index, mL/m2 24.6±8.6 36.7±15.2 0.081
E/A ratio 1.1±0.3 1.9±0.9 0.062
E/e’ ratio 7.4±1.1 13.6±5.5 0.026

Wilcoxon rank sum nonparametric test was used to calculate P value. Values are reported as mean±SD. ACEI indicates angiotensin‐converting enzyme inhibitor; BMI, body mass index; BSA, body surface area; E/A, ratio of early to late filling velocity; E/e’, ratio of early mitral inflow velocity to early diastolic mitral annular velocity; eGFR, estimated glomerular filtration rate, values of >90 were considered to be 90; FEF25–75, forced expiratory flow at 25% to 75% of forced vital capacity; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; HFpEF, heart failure with preserved ejection fraction; LA, left atrial; LV, left ventricular; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide, reported as median (range), with values <25 considered to be 25.